Blue Cross Blue Shield
Won't Cover or Administer
The Boston Globe reports six health insurance companies say they will not cover Biogen's Alzheimer's disease drug and the New York Times says two medical centers will not administer it.
Biocept Lung Cancer Liquid Biopsy Test Obtains Coverage From Blue Cross Affiliate Highmark
After a two-year evaluation in advanced non-small cell lung cancers with Allegheny Health Network, the payor will cover the test for its regional members.
Wide Variation in Genomic Testing Utilization Across US, Report Finds
The report also identified opportunities to improve adoption through dissemination of evidence supporting the clinical and economic utilization of testing.
Interpace Diagnostics Signs Thyroid Cancer Test Coverage Deals With Three BCBS Plans
When used together, ThyGeNext and ThyraMir combine next-generation sequencing of an individual's DNA and RNA along with a microRNA classifier.
Interpace Diagnostics Thyroid Assays Covered In-Network by Blue Shield of California
Blue Shield of California's members will be able to access Interpace's tests on an in-network basis, which will limit their out-of-pocket expenses.